Live Breaking News & Updates on Biocon Biologics Ltd
Stay updated with breaking news from Biocon biologics ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biocon Biologics gets USFDA nod for its biosimilar to treat eye conditions financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Biocon Biologics secures FDA approval for Yesafili, an interchangeable biosimilar to Eylea, for ophthalmological conditions. Launch in Canada set. ....
Biocon Biologics secures US Market entry date for Bmab 1200 maurice-info.mu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from maurice-info.mu Daily Mail and Mail on Sunday newspapers.
Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara® streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today that the Company has signed a settlement and license agreement with Janssen Biotech Inc., and Johnson & Johnson (collectively known as Janssen) that clears the way to commercialize its Bmab 1200, a proposed biosimilar to Stelara®, in the United States of America. ....